ADHD Stimulant Misuse Under Review
High-frequency misuse remains associated with polysubstance use, while no studies evaluated long-term physical health outcomes.
-
By
-
Kathryn Wighton
-
July 17, 2026
-
Clinical Scorecard: ADHD Stimulant Misuse Under Review
At a Glance
| Category | Detail |
|---|
| Condition | ADHD Stimulant Misuse |
| Key Mechanisms | Patterns of misuse, acquisition routes, and health consequences of ADHD stimulant medications. |
| Target Population | US adults, particularly younger adults aged 18-30. |
| Care Setting | Public health and substance use research. |
Key Highlights
- Misuse of ADHD stimulants declined among younger adults, particularly from 2022 to 2023.
- 1.4% of Americans aged 12 and older reported misuse of ADHD stimulant medications in 2023.
- High-frequency misuse is associated with higher rates of polysubstance use.
- Most misuse episodes were oral and infrequent, averaging 4.5 days in the past month.
- Intentional stimulant misuse is linked to higher critical care and psychiatric admission rates.
Guideline-Based Recommendations
Diagnosis
- Monitor patterns of stimulant misuse among adults.
Management
- Address reasons for misuse, including concentration and alertness.
Monitoring & Follow-up
- Track health outcomes related to stimulant misuse, particularly in high-frequency users.
Risks
- Consider the co-occurrence of stimulant misuse with other substance use.
Patient & Prescribing Data
Adults aged 18-30, particularly those in university settings.
High-frequency users are more likely to obtain stimulants from physicians or dealers.
Clinical Best Practices
- Utilize comprehensive assessments to understand misuse patterns.
- Encourage toxicologic confirmation for self-reported misuse data.
- Investigate long-term health outcomes of stimulant misuse.
Related Resources & Content
